AEG3482

Overview

AEG3482 is a potent antiapoptotic compound that inhibits Jun kinase ( JNK ) activity through induced expression of heat shock protein 70 ( HSP70 ). AEG3482 directly binds HSP90 , thereby facilitating HSF1 -dependent expression of HSP70 and HSP25.

Application

Products | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Depression | Products > Disease Areas > Pain | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Parkinson's Disease | Products > Disease Areas > Obesity | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Respiratory Disease | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > JNK | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-107599
• CAS No.: 63735-71-7
• Molecular Formula: C10H8N4O2S2
• Molecular Weight: 280.33
• Purity: 99.79%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.08 mg/mL (7.42 mM); Clear solution
• Availability: In-stock

Source

Original product source